hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Changed name to hVIVO from Retroscreen Virology Group PLC, 4/17/2015.
Ticker:
HVO
ISIN:
GB00B6ZM0X53
Address:
Queen Mary BioEnterp (click to copy or hover over here to view full address)
CSRHub includes data on Environment, current environmental issues, climate change, World Council for Sustainable Business Development, effects of climate change, and Governance.